Published in Am J Physiol Gastrointest Liver Physiol on October 30, 2008
Regulation of cellular iron metabolism. Biochem J (2011) 3.03
Ferroportin-mediated iron transport: expression and regulation. Biochim Biophys Acta (2012) 1.27
Review on iron and its importance for human health. J Res Med Sci (2014) 1.24
Redox cycling in iron uptake, efflux, and trafficking. J Biol Chem (2010) 1.08
The gut in iron homeostasis: role of HIF-2 under normal and pathological conditions. Blood (2013) 0.96
Mechanistic and regulatory aspects of intestinal iron absorption. Am J Physiol Gastrointest Liver Physiol (2014) 0.96
Multi-copper oxidases and human iron metabolism. Nutrients (2013) 0.90
Ironing out Ferroportin. Cell Metab (2015) 0.90
Hepcidin and ferroportin: the new players in iron metabolism. Semin Liver Dis (2011) 0.88
Molecular mediators governing iron-copper interactions. Annu Rev Nutr (2014) 0.84
Regulatory effects of Cu, Zn, and Ca on Fe absorption: the intricate play between nutrient transporters. Nutrients (2013) 0.82
Hypoxia-inducible factor-2α and iron absorptive gene expression in Belgrade rat intestine. Am J Physiol Gastrointest Liver Physiol (2011) 0.80
Anticancer activity of the iron facilitator LS081. J Exp Clin Cancer Res (2011) 0.80
Hepcidin bound to α2-macroglobulin reduces ferroportin-1 expression and enhances its activity at reducing serum iron levels. J Biol Chem (2013) 0.79
Recent advances in small bowel diseases: Part II. World J Gastroenterol (2012) 0.78
Iron uptake and transport across physiological barriers. Biometals (2016) 0.78
Iron repletion relocalizes hephaestin to a proximal basolateral compartment in polarized MDCK and Caco2 cells. Biochem Biophys Res Commun (2012) 0.77
Copper chelation and interleukin-6 proinflammatory cytokine effects on expression of different proteins involved in iron metabolism in HepG2 cell line. BMC Biochem (2017) 0.75
Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science (2004) 19.19
Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature (1997) 9.98
Balancing acts: molecular control of mammalian iron metabolism. Cell (2004) 7.82
Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature (2000) 7.46
Analysis of molecular masses and oligomeric states of protein complexes by blue native electrophoresis and isolation of membrane protein complexes by two-dimensional native electrophoresis. Anal Biochem (1994) 7.30
Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci U S A (2001) 5.77
The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab (2005) 5.32
A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell (2000) 5.31
A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem (2000) 5.21
Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat Genet (1999) 3.30
An iron-regulated ferric reductase associated with the absorption of dietary iron. Science (2001) 2.90
RADIOACTIVE IRON ABSORPTION BY GASTRO-INTESTINAL TRACT : INFLUENCE OF ANEMIA, ANOXIA, AND ANTECEDENT FEEDING DISTRIBUTION IN GROWING DOGS. J Exp Med (1943) 2.70
Molecular physiology of intestinal Na+/H+ exchange. Annu Rev Physiol (2005) 2.58
Methods for the isolation of intact epithelium from the mouse intestine. Anat Rec (1981) 2.33
Ferritin, iron homeostasis, and oxidative damage. Free Radic Biol Med (2002) 2.26
Blue native polyacrylamide gel electrophoresis (BN-PAGE) for the identification and analysis of multiprotein complexes. Sci STKE (2006) 1.87
Iron imports. IV. Hepcidin and regulation of body iron metabolism. Am J Physiol Gastrointest Liver Physiol (2006) 1.81
Functional consequences of ferroportin 1 mutations. Blood Cells Mol Dis (2005) 1.70
Translational repression by a complex between the iron-responsive element of ferritin mRNA and its specific cytoplasmic binding protein is position-dependent in vivo. EMBO J (1990) 1.70
Autosomal dominant reticuloendothelial iron overload associated with a 3-base pair deletion in the ferroportin 1 gene (SLC11A3). Blood (2002) 1.62
Hepcidin regulation of ferroportin 1 expression in the liver and intestine of the rat. Am J Physiol Gastrointest Liver Physiol (2003) 1.43
A rapid decrease in the expression of DMT1 and Dcytb but not Ireg1 or hephaestin explains the mucosal block phenomenon of iron absorption. Gut (2003) 1.40
Decreased hephaestin activity in the intestine of copper-deficient mice causes systemic iron deficiency. J Nutr (2006) 1.23
Evidence for the multimeric structure of ferroportin. Blood (2006) 1.22
Disruption of ferroportin 1 regulation causes dynamic alterations in iron homeostasis and erythropoiesis in polycythaemia mice. Development (2004) 1.21
Radioiron absorption in anemic dogs; fluctuations in the mucosal block and evidence for a gradient of absorption in the gastrointestinal tract. J Exp Med (1950) 1.20
Cloning and gastrointestinal expression of rat hephaestin: relationship to other iron transport proteins. Am J Physiol Gastrointest Liver Physiol (2001) 1.18
Mislocalisation of hephaestin, a multicopper ferroxidase involved in basolateral intestinal iron transport, in the sex linked anaemia mouse. Gut (2004) 1.13
Wild-type and mutant ferroportins do not form oligomers in transfected cells. Biochem J (2006) 1.12
Role of copper in the proteosome-mediated degradation of the multicopper oxidase hephaestin. J Biol Chem (2004) 1.06
Iron Imports. V. Transport of iron through the intestinal epithelium. Am J Physiol Gastrointest Liver Physiol (2006) 1.06
Dietary copper deficiency reduces iron absorption and duodenal enterocyte hephaestin protein in male and female rats. J Nutr (2005) 1.04
Dietary iron induces rapid changes in rat intestinal divalent metal transporter expression. Am J Physiol Gastrointest Liver Physiol (2000) 1.04
Colocalization of ferroportin-1 with hephaestin on the basolateral membrane of human intestinal absorptive cells. J Cell Biochem (2007) 1.02
Analysis of the human hephaestin gene and protein: comparative modelling of the N-terminus ecto-domain based upon ceruloplasmin. Protein Eng (2002) 1.00
The transcytosis of divalent metal transporter 1 and apo-transferrin during iron uptake in intestinal epithelium. Am J Physiol Gastrointest Liver Physiol (2002) 0.88
Regulation of iron metabolism: translational effects mediated by iron, heme, and cytokines. Annu Rev Nutr (1995) 0.88
Transient overexpression of human H- and L-ferritin chains in COS cells. Biochem J (1998) 0.85
Duodenal Dcytb and hephaestin mRNA expression are not significantly modulated by variations in body iron homeostasis. Blood Cells Mol Dis (2005) 0.84
Native proteomic analysis of protein complexes in murine intestinal brush border membranes. Proteomics (2007) 0.83
Ferritin and intestinal iron absorption: pancreatic enzymes and free iron. Am J Physiol (1975) 0.78
Health literacy and cancer communication. CA Cancer J Clin (2002) 4.66
IGF-I and breast cancer: a meta-analysis. Int J Cancer (2004) 2.03
Airway glutathione homeostasis is altered in children with severe asthma: evidence for oxidant stress. J Allergy Clin Immunol (2009) 1.66
Is percutaneous nephrolithotomy in solitary kidneys safe? Urology (2013) 1.55
Percutaneous nephrolithotomy in England: practice and outcomes described in the Hospital Episode Statistics database. BJU Int (2013) 1.53
Preventing familial amyotrophic lateral sclerosis: is a clinical trial feasible? J Neurol Sci (2006) 1.51
Hepcidin regulation of ferroportin 1 expression in the liver and intestine of the rat. Am J Physiol Gastrointest Liver Physiol (2003) 1.43
Defining the learning curve for percutaneous nephrolithotomy. J Endourol (2005) 1.42
Mammalian target of rapamycin inhibitors as possible adjuvant therapy for microscopic residual disease in head and neck squamous cell cancer. Cancer Res (2007) 1.38
Incidental renal stones in potential live kidney donors: prevalence, assessment and donation, including role of ex vivo ureteroscopy. BJU Int (2012) 1.32
Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway. Clin Cancer Res (2004) 1.31
Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I safety trial, technical note, and lumbar safety outcomes. Neurosurgery (2012) 1.27
Thymoquinone and cisplatin as a therapeutic combination in lung cancer: In vitro and in vivo. J Exp Clin Cancer Res (2010) 1.20
Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosis. PLoS One (2013) 1.19
Primary plasma cell leukemia: report of 17 new cases treated with autologous or allogeneic stem-cell transplantation and review of the literature. Am J Hematol (2005) 1.16
Comparison of radiosensitizing effects of the mammalian target of rapamycin inhibitor CCI-779 to cisplatin in experimental models of head and neck squamous cell carcinoma. Mol Cancer Ther (2009) 1.10
RUNX1 (AML-1) and RUNX2 (AML-3) cooperate with prostate-derived Ets factor to activate transcription from the PSA upstream regulatory region. J Cell Biochem (2006) 1.07
Iron Imports. V. Transport of iron through the intestinal epithelium. Am J Physiol Gastrointest Liver Physiol (2006) 1.06
Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I trial, cervical microinjection, and final surgical safety outcomes. Neurosurgery (2014) 1.04
Multimodal management of urolithiasis in renal transplantation. BJU Int (2005) 1.03
Race/Ethnicity has no effect on outcome for breast cancer patients treated at an academic center with a public hospital. Cancer Epidemiol Biomarkers Prev (2009) 0.99
Case report: percutaneous nephrolithotomy for a stone on a Hem-o-lok clip. J Endourol (2008) 0.98
Reduced CSF p-Tau181 to Tau ratio is a biomarker for FTLD-TDP. Neurology (2013) 0.95
Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS. Amyotroph Lateral Scler (2012) 0.95
Trogocytosis of MHC-I/peptide complexes derived from tumors and infected cells enhances dendritic cell cross-priming and promotes adaptive T cell responses. PLoS One (2008) 0.95
The phenotypic radiation resistance of CD44+/CD24(-or low) breast cancer cells is mediated through the enhanced activation of ATM signaling. PLoS One (2011) 0.94
Interleukin-6 protects against paclitaxel, cisplatin and vincristine-induced neuropathies without impairing chemotherapeutic activity. Cancer Chemother Pharmacol (2008) 0.93
Interactions between ferroportin and hephaestin in rat enterocytes are reduced after iron ingestion. Gastroenterology (2011) 0.93
Three 'Pages' in a chapter of accidents. Nephrol Dial Transplant (2003) 0.92
Down regulation of PSA by C/EBPalpha is associated with loss of AR expression and inhibition of PSA promoter activity in the LNCaP cell line. BMC Cancer (2006) 0.89
Commercial insurance triples chances of breast cancer survival in a public hospital. Breast J (2013) 0.88
The transcytosis of divalent metal transporter 1 and apo-transferrin during iron uptake in intestinal epithelium. Am J Physiol Gastrointest Liver Physiol (2002) 0.88
Behavior matters--cognitive predictors of survival in amyotrophic lateral sclerosis. PLoS One (2013) 0.87
Systemic pharmacokinetics and cerebrospinal fluid uptake of intravenous ceftriaxone in patients with amyotrophic lateral sclerosis. J Clin Pharmacol (2014) 0.87
In prostate cancer cells the interaction of C/EBPalpha with Ku70, Ku80, and poly(ADP-ribose) polymerase-1 increases sensitivity to DNA damage. J Biol Chem (2006) 0.86
Pharmacodynamic evaluation of temsirolimus in patients with newly diagnosed advanced-stage head and neck squamous cell carcinoma. Head Neck (2010) 0.86
In prostate cancer C/EBPalpha promotes cell growth by the loss of interactions with CDK2, CDK4, and E2F and by activation of AKT. Prostate (2009) 0.85
DMT1 (IRE) expression in intestinal and erythroid cells is regulated by peripheral benzodiazepine receptor-associated protein 7. Am J Physiol Gastrointest Liver Physiol (2012) 0.85
Stable expression of C/EBPalpha in prostate cancer cells down-regulates metallothionein and increases zinc-induced toxicity. Prostate (2005) 0.83
A phase 1/2 trial of HQK-1001, an oral fetal globin inducer, in sickle cell disease. Am J Hematol (2012) 0.83
Association of core-binding factor β with the malignant phenotype of prostate and ovarian cancer cells. J Cell Physiol (2010) 0.83
Impact of race and ethnicity on outcomes for estrogen receptor-negative breast cancers: experience of an academic center with a charity hospital. J Am Coll Surg (2010) 0.83
Flexible ureterorenoscopy (URS) for lower pole calculi. BJU Int (2012) 0.82
Activated 5'flanking region of NANOGP8 in a self-renewal environment is associated with increased sphere formation and tumor growth of prostate cancer cells. Prostate (2013) 0.81
Priming of immune responses against transporter associated with antigen processing (TAP)-deficient tumours: tumour direct priming. Immunology (2009) 0.81
Improving the interpretation of ureteroscopic biopsies: use of Bouin's fixative. BJU Int (2011) 0.81
Generalized tetanus despite prior vaccination and a protective level of anti-tetanus antibodies. Am J Med Sci (2010) 0.80
A randomized controlled trial of human versus robotic and telerobotic access to the kidney as the first step in percutaneous nephrolithotomy. Comput Aided Surg (2005) 0.80
Hypoxia-inducible factor-2α and iron absorptive gene expression in Belgrade rat intestine. Am J Physiol Gastrointest Liver Physiol (2011) 0.80
Anticancer activity of the iron facilitator LS081. J Exp Clin Cancer Res (2011) 0.80
PET imaging today: contribution to the initial staging and prognosis of patients with non-Hodgkin's lymphomas. J La State Med Soc (2006) 0.79
Effect of B7.1 costimulation on T-cell based immunity against TAP-negative cancer can be facilitated by TAP1 expression. PLoS One (2009) 0.79
In vivo survivors of transformed mouse ovarian surface epithelial cells display diverse phenotypes for gene expression and tumorigenicity. Tumour Biol (2008) 0.78
Management of cystinuric patients: an observational, retrospective, single-centre analysis. Urol Int (2008) 0.78
Treatment of acute myeloid leukemia in a Jehovah's Witness. Ann Hematol (2006) 0.77
MOZ-TIF2 repression of nuclear receptor-mediated transcription requires multiple domains in MOZ and in the CID domain of TIF2. Mol Cancer (2007) 0.77
ALS Untangled No. 20: the Deanna protocol. Amyotroph Lateral Scler Frontotemporal Degener (2013) 0.77
NS 398 radiosensitizes an HNSCC cell line by possibly inhibiting radiation-induced expression of COX-2. Int J Radiat Oncol Biol Phys (2003) 0.77
Iron facilitator LS081 reduces hypoxia-inducible factor-1α protein and functions as anticancer agent in hepatocellular carcinoma. Cancer Sci (2012) 0.76
Findings that hospital factors are surrogate for disparities are misleading. J Clin Oncol (2009) 0.75
Kidney stones. BMJ Clin Evid (2009) 0.75
The evolution of ureteroscopy. Int J Clin Pract (2007) 0.75
Kidney stones. BMJ Clin Evid (2007) 0.75
The Shreveport Myeloma Experience: Survival, Risk Factors and Other Malignancies in the Age of Stem Cell Transplantation. Acta Haematol (2015) 0.75
Controlled intermittent asystole cardiac therapy induced by pharmacologically potentiated vagus nerve stimulation in normal and hibernating myocardium. Ann Thorac Surg (2003) 0.75
Spontaneous passage of large ureteric stone in a child. N Z Med J (2008) 0.75